BMAA and Neurodegenerative Illness

Area of Science:

• Neuroscience
• Toxicology
• Environmental Health

Background:

• Cyanobacterial toxin β-N-methylamino-L-alanine (BMAA) is implicated in Guamanian amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC).
• BMAA is produced by cyanobacteria globally.
• Multiple neurotoxic mechanisms of BMAA, especially for motor neurons, are known.

Purpose of the Study:

• To provide an overview of existing BMAA research.
• To introduce a collection of manuscripts focused on BMAA.

Main Methods:

• Literature review of BMAA studies.
• Introduction to a special issue on BMAA.

Main Results:

• BMAA is a significant factor in Guamanian ALS/PDC.
• Increased global interest in BMAA exposure as a neurodegenerative risk factor.
• This collection of manuscripts explores various facets of BMAA.

Conclusions:

• BMAA's role in neurodegeneration warrants further investigation.
• Understanding BMAA's impact is crucial for public health.
• This special issue provides a comprehensive resource on BMAA research.